Nortriptyline

This MedLibrary.org supplementary page on Nortriptyline is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Nortriptyline
Systematic (IUPAC) name
3-(10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5-ylidene)- N-methyl-1-propanamine
Identifiers
CAS number 72-69-5 894-71-3 (hydrochloride)
ATC code N06AA10
PubChem 4543
DrugBank APRD00602
Chemical data
Formula C19H21N 
Mol. mass 263.377 g/mol
Pharmacokinetic data
Bioavailability well absorbed
Metabolism Hepatic
Half life 16 and 90 hours
Excretion Renal
Therapeutic considerations
Pregnancy cat.

C

Legal status

Prescription only

Routes oral

Nortriptyline is a second generation tricyclic antidepressant marketed as the hydrochloride under the trade names Sensoval, Aventyl, Pamelor, Allegron and Nortrilen. It is used in the treatment of major depression and childhood nocturnal enuresis (bedwetting). In addition it is sometimes used for chronic illnesses such as chronic fatigue syndrome, chronic pain and migraines, and labile affect in some neurological conditions.

Contents

Clinical pharmacology

Nortriptyline inhibits the reuptake of norepinephrine (noradrenaline), and, to a lesser extent, serotonin. Nortryptiline also presents clinicically relevant post-synaptic antagonism of muscarinergic and 5HT2A receptors [1]. The former is responsible for anticholinergic side effects whereas the affinity for 5HT2A may be responsible for its sleep improving effect[2]. In the short run however, nortryptiline may disturb sleep due to its activating effect.

Indications

Nortriptyline is FDA approved for the treatment of major depression. In the United Kingdom it may also be used for treating nocturnal enuresis with courses of treatment lasting no more than three months. It is also used off-label for the treatment of panic disorder, irritable bowel syndrome, prevention of migraine headaches and chronic pain or neuralgia modification (particularly TMJ disorder).[3] It can also aid in quitting smoking with one study showing a six-month abstinence rate of 14% for subjects receiving nortriptyline compared to 3% for subjects not undergoing pharmacological treatment.[4] Research has been done suggesting it can reduce symptoms of ADHD.citation needed It should however be noted, that the co-administration of Tricyclic Antidepressants and stimulant ADD medications is highly inadvisable. Due to the blocking effect such medications have on both norepinephrine and serotonin, the stimulant properties of ADD medications can be severely potentiated, resulting in a risk of hypertension, tachycardia and central overstimulation.

Metabolism

Nortriptyline is metabolised in the liver by hepatic enzyme CYP2D6. Approximately 7 to 10 percent of caucasians are poor metabolisers and might experience more adverse effects, so a lower dosage is often necessary in these individuals.citation needed Blood levels of nortriptyline should be obtained during long term treatment to avoid toxicity and optimise response.

Dosage

For depression: low starting doses are used, increasing as necessary to 75–100mg (0–50mg for adolescents and the elderly). Maximum daily dosage is 150mg.[5]

For the management of nocturnal enuresis: lower dosages are used with the maximum period of treatment, including gradual withdrawal, being three months and a full examination including electrocardiogram (ECG or EKG) required before further courses.[5]

For its off-label use for migraine and headache prophylaxis and treating chronic pain: treatment is started at very low 10mg once at night to minimise side-effects. The dose is then increased every two weeks if required to a maximum of 150mg.

Side effects

Dry mouth, drowsiness, orthostatic hypotension, urinary retention, constipation, and rapid or irregular heartbeat. Some sexual side effects may be a problem as well. Less commonly, seizures and ECG/EKG changes have been reported, especially in overdose.

Alcohol may exacerbate some of its side effects and should be avoided.

However, the incidence of side effects with nortriptyline is somewhat lower than with the first generation tricyclics (e.g. imipramine (Tofranil), amitriptyline (Elavil)).

Warnings

Closer monitoring is required for those with a history of cardiovascular disease, stroke, glaucoma and/or seizures as well as those who have hyperthyroidism or are receiving thyroid medication.

Excessive consumption of alcohol in combination with nortriptyline therapy may have a potentiating effect, which may lead to the danger of increased suicidal attempts or overdosage, especially in patients with histories of emotional disturbances or suicidal ideation.

Troublesome patient hostility may be aroused by the use of nortriptyline.

Contraindications

In the acute recovery phase after myocardial infarction (e.g. heart attack). As for all tricyclic antidepressants, concurrent use, or failure to allow a two week gap, with monoamine oxidase inhibitors (MAO inhibitors, e.g. phenelzine, tranylcypromine, etc.) may precipitate hyperpyretic crisis and/or severe convulsions; fatalities have occurred.

Overdose

The symptoms and the treatment of an overdose are largely the same as for the other tricyclic antidepressants.

References

  1. ^ Gillman PK (2007), "Tricyclic antidepressant pharmacology and therapeutic drug interactions updated", Br J Pharmacol 151(6): 737–48, doi:10.1038/sj.bjp.0707253, PMID 17471183 
  2. ^ Thase ME (2006), "Depression and sleep: pathophysiology and treatment", Dialogues Clin Neurosci 8(2): 217–26, PMID 16889107 
  3. ^ (2002) in Sweetman SC: Martindale. The complete drug reference, 33, Pharmaceutical Press. ISBN 0-85369-499-0. 
  4. ^ Prochazka A, Weaver M, Keller R, Fryer G, Licari P, Lofaso D (1998), "A randomized trial of nortriptyline for smoking cessation", Arch Intern Med 158(18): 2035–9, doi:10.1001/archinte.158.18.2035, PMID 9778204 
  5. ^ a b British National Formulary 45 March 2003

External links

Wikipedia content modification information:

  • This page was last modified on 29 September 2008, at 23:38.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Nortriptyline".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.